TY  - GEN
AU  - Soloway,M S
AU  - Briggman,V
AU  - Carpinito,G A
AU  - Chodak,G W
AU  - Church,P A
AU  - Lamm,D L
AU  - Lange,P
AU  - Messing,E
AU  - Pasciak,R M
AU  - Reservitz,G B
AU  - Rukstalis,D B
AU  - Sarosdy,M F
AU  - Stadler,W M
AU  - Thiel,R P
AU  - Hayden,C L
TI  - Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment
SN  - 0022-5347
PY  - 1996///0820
KW  - Biomarkers, Tumor
KW  - urine
KW  - Carcinoma, Transitional Cell
KW  - diagnosis
KW  - Confidence Intervals
KW  - Cystoscopy
KW  - Follow-Up Studies
KW  - Humans
KW  - Neoplasm Recurrence, Local
KW  - Nuclear Proteins
KW  - Predictive Value of Tests
KW  - ROC Curve
KW  - Reagent Kits, Diagnostic
KW  - Reproducibility of Results
KW  - Sensitivity and Specificity
KW  - Time Factors
KW  - Urinary Bladder Neoplasms
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1097/00005392-199608000-00008
ER  -